Individuals who carry the -308A TNFA gene variant have a 23% greater risk of developing obesity compared with controls, and they showed significantly higher systolic arterial blood pressure and plasma insulin levels, supporting the hypothesis that the TNFA gene is involved in the pathogenesis of the metabolic syndrome [43]. This evidence concerns the gene INS and metabolic syndrome.